Roche Satellite Symposium: “The Value of High-Efficacy Therapy for MS Patients”
| Moderators Introduction | 5 min | 1) Professor Nikolaos Grigoriadis (GR) 2) TBC (TR) |
| Societal Value: Addressing the broader impact on patients’ lives and healthcare systems | 15 min | Professor Dr. Uroš Rot (SLO) |
| Ocrelizumab as HET: Demonstrating the clinical value and long-term outcomes for patients | 15 min | Professor Rodica Ioana Balasa (RO) |
| Ocrelizumab SC: Focus on the latest Efficacy and Safety data | 15 min | Professor Ivan Milanov (BG) |
| Discussion | 10 min | All |